|
1
|
O'Brien S, Thall PF and Siciliiano MJ:
Cytogenetics of chronic myelogeneous leukemia. Baillie'res Clin
Hematol. 10:259–276. 1997.
|
|
2
|
Shtivelman E, Lifshitz B, Gale RP and
Canaani E: Fused transcript of abl and bcr genes in chronic
myelogenous leukemia. Nature. 315:550–554. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Griffen J: The biology of signal
transduction inhibition: basic science to novel therapies. Semin
Oncol. 28:3–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kantarjian H, Sawyers C, Hochhaus A,
Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D,
Resta D, Capdeville R, Zoellner U, Talpaz M, et al: International
STI571 CML Study Group: Hematologic and cytogenetic responses to
imatinib mesylate in chronic myelogenous leukemia. N Engl J Med.
346:645–652. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cortes JE, Talpaz M, Giles F, O'Brien S,
Rios MB, Shan J, Garcia-Manero G, Faderl S, Thomas DA, Wierda W,
Ferrajoli A, et al: Prognostic significance of cytogenetic clonal
evolution in patients with chronic myelogenous leukemia on imatinib
mesylate therapy. Blood. 101:3794–3800. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al-Achkar W, Wafa A and Nweder MS: A
complex translocation t(5;9;22) in Philadelphia cells involving the
short arm of chromosome 5 in a case of chronic myelogenous
leukemia. J Exp Clin Cancer Res. 26:411–415. 2007.PubMed/NCBI
|
|
7
|
Shaffer L, Slovak M and Cambell L: ISCN
2009 An International System for Human Cytogenetic Nomenclature. S
Karger; Basel: 2009
|
|
8
|
Weise A, Mrasek K, Fickelscher I, Claussen
U, Cheung SW, Cai WW, Liehr T and Kosyakova N: Molecular definition
of high-resolution multicolor banding probes: first within the
human DNA sequence anchored FISH banding probe set. J Histochem
Cytochem. 56:487–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liehr T, Heller A, Starke H, Rubtsov N,
Trifonov V, Mrasek K, Weise A, Kuechler A and Claussen U:
Microdissection based high resolution multicolor banding for all 24
human chromosomes. Int J Mol Med. 9:335–339. 2002.PubMed/NCBI
|
|
10
|
El-Zimaity MM, Kantarjian H, Talpaz M,
O'Brien S, Giles F, Garcia-Manero G, Verstovsek S, Thomas D,
Ferrajoli A, Hayes K, et al: Results of imatinib mesylate therapy
in chronic myelogenous leukaemia with variant Philadelphia
chromosome. Br J Haematol. 125:187–195. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartram CR, Anger B, Carbonell F and
Kleihauer E: Involvement of chromosome 9 in variant Ph1
translocation. Leuk Res. 9:1133–1137. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guillaume B, Ameye G, Libouton JM,
Dierlamm J, Vaerman JL, Straetmans N, Ferrant A, Verellen-Dumoulin
C and Michaux L: Chronic myeloid leukemia with a rare variant
Philadelphia translocation: t(9;22;21)(q34;q11;q22). Cancer Genet
Cytogenet. 116:166–169. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mancini M, Nanni M, Cedrone M, De Cuia MR,
Rondinelli MB, Malagnino F and Alimena G: Application of
fluorescence in situ hybridization in defining a complex t(9;21;22)
Ph formation. Haematologica. 79:536–539. 1994.PubMed/NCBI
|
|
14
|
Vallcorba I, García-Sagredo JM, San Román
C, Ferro MT, González A, Cabello P and Villegas A: Translocation
(9;22;21) in a chronic myeloid leukemia fluorescence in situ
hybridization definition. Cancer Genet Cytogenet. 104:72–73.
1998.PubMed/NCBI
|
|
15
|
Zhang J, Meltzer P, Jenkins R, Guan XY and
Trent J: Application of chromosome microdissection probes for
elucidation of BCR-ABL fusion and variant Philadelphia chromosome
translocations in chronic myelogenous leukemia. Blood.
81:3365–3371. 1993.
|
|
16
|
Calabrese G, Stuppia L, Franchi PG, et al:
Complex translocations of the Ph chromosome and Ph negative CML
arise from similar mechanisms, as evidenced by FISH analysis.
Cancer Genet Cytogenet. 78:153–159. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takeuchi M, Katayama Y, Okamura A,
Yamamoto K, Shimoyama M and Matsui T: Chronic myeloid leukemia with
a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
Cancer Genet Cytogenet. 179:85–87. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mitelman F, Johansson B and Mertens F:
Mitelman Database of Chromosome Aberrations in Cancer. 2009,
http://cgap.nci.nih.gov/Chromosomes/Mitelman.
|
|
19
|
Johansson B and Fioretos T: Cytogenetic
and molecular genetic evolution of chronic myeloid leukemia. Acta
Haematol. 107:76–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jeandidier E, Dastugue N, Mugneret F,
Lafage-Pochitaloff M, Mozziconacci MJ, Herens C, Michaux L,
Verellen-Dumoulin C, Talmant P, Cornillet-Lefebvre P, Luquet I,
Charrin C, Barin C, Collonge-Rame MA, Pérot C, Van den Akker J,
Grégoire MJ, Jonveaux P, Baranger L, Eclache-Saudreau V, Pagès MP,
Cabrol C, Terré C and Berger R; Groupe Français de Cytogénétique
Hématologique (GFCH). Abnormalities of the long arm of chromosome
21 in 107 patients with hematopoietic disorders: a collaborative
retrospective study of the Groupe Français de Cytogénétique
Hématologique. Cancer Genet Cytogenet. 166:1–11. 2006.PubMed/NCBI
|
